We used 6-thio-GTP, an inhibitor of the Vav1/Rac1 pathway, to pretreat the macrophages, and the results showed that the effect of CML on the migration of foam cells was blocked. The gene discussed is RAC1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.